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Abstract 
Background: A sex-difference in susceptibility to chronic pain is well-known. Although recent studies have begun to 
reveal the sex-dependent mechanisms of nerve injury-induced pain sensitization, sex differences in the affective and 
cognitive brain dysfunctions associated with chronic pain have not been investigated. Therefore, we tested whether 
chronic pain leads to affective and cognitive disorders in a mouse neuropathic pain model and whether those disor-
ders are sexually dimorphic.
Methods: Chronic neuropathic pain was induced in male and female mice by L5 spinal nerve transection (SNT) 
injury. Pain sensitivity was measured with the von Frey test. Affective behaviors such as depression and anxiety were 
assessed by the forced swim, tail suspension, and open field tests. Cognitive brain function was assessed with the 
Morris water maze and the novel object location and novel object recognition tests.
Results: Mechanical allodynia was induced and maintained for up to 8 weeks after SNT in both male and female 
mice. Depressive- and anxiety-like behaviors were observed 8 weeks post-SNT injury regardless of sex. Chronic pain-
induced cognitive deficits measured with the Morris water maze and novel object location test were seen only in 
male mice, not in female mice.
Conclusions: Chronic neuropathic pain is accompanied by anxiety- and depressive-like behaviors in a mouse model 
regardless of sex, and male mice are more vulnerable than female mice to chronic pain-associated cognitive deficits.
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Background
Neuropathic pain is chronic pathologic pain that develops 
due to lesions or dysfunctions in the nervous system. The 
prevalence of neuropathic pain in developed countries is 
estimated to be 2% to 3% [1] and is expected to increase 
during the next few decades as the populations of cancer 
survivors and obesity patients experiencing neuropathic 
pain increase. Chronic pain, including neuropathic pain, 
is often accompanied by affective disorders, particularly 
anxiety and depression, and cognitive impairment. Clini-
cal studies have revealed that more than half of patients 
with chronic pain have major depression [2, 3]. The co-
morbidity of depression and chronic pain has been also 
described in several studies using animal models, but a 
causal relationship has not been clearly demonstrated 
[4–7].
There are well-known sex differences in susceptibility 
to chronic pain. In general, females have a much higher 
prevalence of chronic pain [8]; however, the vast major-
ity of animal research on pain has been performed using 
males [9, 10]. Of interest, recent studies using mouse 
models have shown a sex difference in the mechanisms 
of nerve injury-induced neuropathic pain. In male mice, 
activation of the spinal cord microglia is responsible for 
nerve injury-induced central sensitization [11]. However, 
in female mice, nerve injury-induced central sensitization 
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by spinal cord-recruited T cells. In addition, intrathecal 
lipopolysaccharide administration induces spinal cord 
microglial activation and central pain sensitization only 
in male mice [12]. Therefore, spinal cord microglial acti-
vation is differentially involved in inducing chronic pain, 
which might underlie the sexual dimorphism in the sus-
ceptibility to chronic pain.
Of note, sexual dimorphism also manifests in clinical 
studies of affective and cognitive disorders such as major 
depression and anxiety. The prevalence of major depres-
sion in females is about twice that in males [13–15]. Also, 
more females have anxiety disorder than males [16–18]. 
Likewise, epidemiologic studies report that females make 
up almost two-thirds of patients with Alzheimer’s dis-
ease in the United States [19], even though males might 
have a greater risk for mild cognitive impairment [20, 
21]. The comorbidity of depression and chronic pain 
is also higher in females than in males [8]. Consider-
ing the highly prevalent sexual dimorphism in affective 
and cognitive disorders, it is possible that susceptibility 
to chronic pain-associated affective and cognitive brain 
dysfunctions vary by sex, but that idea has not been for-
mally addressed. In this study, we explored that possibil-
ity using a spinal nerve injury-induced neuropathic pain 
model, and we provide evidence of sexual dimorphism in 
chronic pain-associated cognitive disorders.
Methods
Animals
Male and female C57BL/6  J mice (8  weeks old) were 
used for this experiment. Food and water were provided 
ad libitum. Lights were maintained on a 12 h light–dark 
cycle. All experiments were performed in the light phase. 
All experiments were approved by the Institutional Ani-
mal Care and Use Committee of Seoul National Univer-
sity and conducted according to National Institutes of 
Health guidelines.
Neuropathic pain model
Animal treatments were performed in accordance with 
guidelines from the International Association for the 
Study of Pain. A persistent pain model was induced 
using L5 spinal nerve transection (SNT), as previously 
described [22]. Briefly, under anesthesia with pentobar-
bital sodium (50 mg/kg, i.p.), an incision was made in the 
skin above the spinal processes at the L4-S2 level. The 
paraspinal muscles were separated, and the L6 vertebral 
transverse process was carefully removed with small scis-
sors. The right L5 spinal nerve was exposed and carefully 
transected with small scissors. Then, 10% povidone-
iodine solution was applied to the surgical site, which was 
closed in 2 layers with surgical staples. Sham-operated 
mice underwent removal of the L6 transverse process. 
All procedures were performed under sterile conditions. 
Animals that had been operated on were monitored on a 
warm pad during recovery.
Behavioral tests
Mechanical allodynia was assessed by the von Frey test. 
Activity during the open field test, forced swim test, tail 
suspension test, Morris water maze, novel object rec-
ognition test, and novel object location test was video 
recorded and, except for the tail suspension test, auto-
matically analyzed by a computer-operated tracking 
system. Investigators scored the tail suspension test by 
watching the videos.
von Frey test
Animals were habituated to the testing environment daily 
for 3 days. To measure mechanical allodynia, mice were 
placed in clear plastic chambers on an elevated table and 
allowed to acclimate for approximately 30 min. The up-
down method was used with a set of von Frey filaments 
(0.02–2 g; North Coast Medical, Morgan Hill, CA, USA) 
to determine the 50% withdrawal threshold, as previously 
described [22].
Open field test
Mice were placed in a 40 × 40 cm field surrounded by a 
30 cm high wall. Total distance traveled, time spent, and 
distance in the center and periphery were recorded. Data 
were collected over a 5 min period.
Tail suspension test
The tail suspension test was performed for a 5 min test 
session. Mice were suspended 60  cm above the floor in 
a visually isolated area using adhesive tape placed 1  cm 
from the tip of the tail, and their behavior was recorded 
over a 5 min test period.
Forced swim test
The forced swim test was performed with plastic cylin-
ders (25  cm height × 10  cm diameter) filled with water 
(23 °C) to 5 cm from the top. Mice were placed in the cyl-
inders, and their behavior was recorded over a 6 min test 
period. The recording period consisted of 2 min of habit-
uation and 4 min of testing. Data acquisition and analysis 
were performed automatically using the SMART system 
(V3.0, Panlab, Barcelona, Spain).
Morris water maze test
The Morris water maze test was performed to assess 
spatial learning and memory, as previously described 
[23]. Mice were tested at the same time each day (1:00–
4:00 p.m.) using a 100 cm diameter tank filled with 21 °C 
water. Four 60 s trials per day were performed for 5 days. 
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After starting from a designated point, the mice had 60 s 
to find a 10  cm platform located 1  cm below the water 
surface made opaque with nontoxic paint powder. After 
reaching the platform or spending 60  s swimming, the 
mouse was left on the platform for 30 s and then returned 
to a cage for 10–15  min. Training was conducted by a 
visible trial test on the first day followed by a probe trial 
(60 s) on the sixth day using a video tracking SMART sys-
tem that recorded latency, distance to reach the platform, 
and time spent in each platform quadrant.
Object location recognition test
Mice explored the same box for four consecutive days 
during the open field test. Training and testing were con-
ducted as previously described [24]. The session con-
sisted of habituation to an empty area and then three 
training sessions with two distinct objects. The arena and 
objects were wiped down after each session with 70% 
ethanol to remove olfactory stimuli. Following 5  min of 
training, mice were re-exposed to the arena for 5  min 
with one object displaced to a novel location. Testing 
sessions were video monitored, and object exploration 
times were scored off-line by an experimenter blinded to 
the object location recognition test. Interaction time and 
a discrimination index (new place-old place/total time) 
during the test session were scored.
Novel object recognition test
The novel object recognition test was performed using 
previously described methods [25] with minor modifica-
tions. On the first day of the experiment, each mouse was 
placed on one side of the open field box and allowed to 
freely explore for 5  min, which was repeated for 3 con-
secutive days. After familiarization, two identical objects 
were presented to each mouse for 5 min. After 5 min of 
exploration, one object was replaced with a novel object, 
and the mouse was allowed to explore for 5  min. The 
chamber and objects were cleaned with 70% ethanol 
between trials to remove olfactory stimuli. Results are 
expressed as the interaction time and discrimination 
ratio of time spent with the novel object to the total 
exploration time.
Statistics
Statistical analyses were performed and graphs were 
made using GraphPad Prism 7.0 for Windows software 
(Software Inc., La Jolla, CA, USA). All data are expressed 
and plotted as the mean ± SEM. P < 0.05 and P < 0.01 
were considered statistically significant. Statistical tests 
between groups were made using unpaired t-testing for 
all behavioral tests except the Morris water maze. Morris 
water maze values were analyzed using two-way ANOVA 
with repeated measures. For the power calculation in 
novel object location and novel object tests, we per-
formed a priori analysis using G* Power 3.1 software with 
α = 0.05 and power (1 − β) = 0.80.
Results
SNT‑injured mice develop depressive‑ and anxiety‑like 
behaviors regardless of sex
The experimental design of this study is presented in 
Fig.  1. To investigate putative sexual dimorphism in 
chronic pain-associated affective and cognitive disor-
ders, we first assessed whether SNT induces compa-
rable levels of chronic pain phenotypes in male and 
female mice. Mechanical allodynia was assessed by 
measuring mechanical withdrawal thresholds in von 
Frey testing of the ipsilateral hind paws in sham control 
and SNT-injured mice from 1  week until 8  weeks post-
injury (Fig. 2a). At 1 week, the 50% withdrawal threshold 
decreased to 0.15 g and 0.16 g in male and female mice, 
respectively, which was maintained for up to 8  weeks. 
There was no significant difference in the withdrawal 
thresholds between male and female mice during the 
entire test period (Fig. 2a).
Fig. 1 Schematic representation of experimental design for behavioral tests. MWM Morris water maze test, NOR novel object test, NOL novel object 
location test
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To test whether SNT-induced chronic pain is accompa-
nied by affective disorders in mice, anxiety-like behaviors 
were first assessed in the open field test. Time spent in 
the central area in the open field test decreased by 46% 
and 42% in male and female SNT-injured mice, respec-
tively, compared with sham control mice (Fig. 2b and e, F 
(9, 11) = 6.047, P < 0.01, F (7, 6) = 21.63, P < 0.01). Accord-
ingly, time spent on the periphery increased in both male 
and female mice (Fig. 2b and e, F (9, 11) = 6.047, P < 0.01, 
F (7, 6) = 21.63, P < 0.01). These are behaviors gener-
ally deemed to indicate anxiety. Likewise, the distance 
moved in the center by the SNT-injured mice decreased 
significantly (Fig. 2c and f, F (8, 11) = 4.698, P < 0.05, F (7, 
6) = 6.773, P < 0.05) and that on the periphery increased 
(Fig. 2c and f, F (8, 11) = 4.698, P < 0.05, F (7, 6) = 6.773, 
P < 0.05) regardless of sex. However, the total distance 
traveled did not differ between the SNT-injured and 
sham control mice (Fig. 2d, g), indicating that the behav-
ioral phenotype is not merely a result of motor dysfunc-
tion after SNT. Taken together, these results indicate that 
anxiety-like behavior developed in the SNT-injured mice 
independent of sex.
Fig. 2 SNT induced anxiety-like behavior in both male and female mice. a SNT caused a significant reduction in the hind paw mechanical 
withdrawal thresholds of both male (n = 8 and 9 for the SNT and sham groups, respectively) and female (n = 7 and 8 for the SNT and sham groups, 
respectively) mice. b, e Average percentage of time spent in the center or periphery during an open field test of male and female sham control 
and SNT-injured mice. Both male and female SNT-injured mice spent less time in the field center and more time on the periphery than male and 
female sham control mice. c, f Average percentage of distance moved in the field center or periphery during the open field test. Both male and 
female SNT-injured mice traveled a shorter distance in the field center and a longer distance on the periphery than the sham control group. d, g 
Total distance moved during the open field test. Data are presented as the mean ± SEM, male: n = 9 for sham, n = 12 for SNT; female: n = 7 for sham, 
n = 8 for SNT. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the sham group
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Depressive-like behaviors were then assessed with the 
forced swim and tail suspension tests, two well-known 
behavioral tests used to assess mouse depression [26]. 
Immobility time in the tail suspension test, an indication 
of a depressive phenotype, increased in both male and 
female mice (Fig. 3b, d) 8 weeks after SNT. The increase 
rate did not differ statistically between these two groups: 
it increased 45% in male mice and 38% in female mice 
compared with the sham control mice (Fig.  3, F (11, 
11) = 3.585, P < 0.05, F (7, 7) = 5.317, P < 0.05). A slight 
but significant increase in immobility in the forced swim 
test was observed in SNT-injured female mice but not in 
male mice (Fig. 3a, c, F (7, 7) = 6.697, P < 0.05). These data 
suggest that depressive-like symptoms developed in both 
male and female mice exposed to chronic neuropathic 
pain via SNT for 2 months. However, the level of depres-
sive-like behavior might differ between male and female 
mice depending on the tests performed.
Sexual dimorphism in chronic neuropathic pain‑associated 
cognitive deficits
To test whether chronic pain affects cognitive function, 
mice were subjected to the Morris water maze test to 
evaluate their spatial learning and memory. In the hidden 
platform test (Fig.  4a), a significant decrease in escape 
latency was observed between the sham and SNT groups 
of males at 5  days. In contrast, no significant difference 
was observed in escape latency between the sham and 
SNT groups of females (Fig. 4b). Memory retention was 
assessed 24  h after the final trial in the absence of the 
escape platform. In the probe trials, male SNT-injured 
mice had significantly reduced travel time and distance in 
the target quadrant area compared with the sham control 
group (Fig. 4c, d, F (8, 11) = 4.929, P < 0.05), whereas no 
significant difference was found between the female sham 
and SNT groups (Fig.  4g, h). Male SNT-injured mice 
traveled a greater distance to reach the target quadrant 
compared with the sham group (Fig. 4e, F (8, 11) = 4.44, 
P < 0.05), whereas no significant difference was found 
between the female sham and SNT mice (Fig. 4i, g).
To further confirm a sex-dependent cognitive deficit 
after SNT, the SNT-injured mice were subjected to an 
object location recognition test and a novel object recog-
nition test. Again, the male SNT-injured mice showed a 
higher preference for the object in a familiar place than in 
a novel place compared with the male sham control mice 
(Fig. 5a, b). Male SNT-injured mice spent less time inter-
acting with the object in a novel location than the male 
sham mice (Fig.  5a, P < 0.05). Thus, the discrimination 
index on the interaction time of the male SNT-injured 
mice in a novel place was significantly lower than that 
of the sham group (Fig.  5b, F (11, 11) = 4.732, P < 0.05). 
In contrast, the discrimination index of the female SNT 
and sham groups did not differ (Fig. 5d, e). Our analysis 
of the total exploration duration (novel + familiar loca-
tion) showed no significant differences between groups 
in either sex (Fig. 5c–f). For the novel object recognition 
test, the interaction time did not differ between the sham 
and SNT groups for male or female mice (Fig.  5g–l). 
Thus, the discrimination ratio did not differ significantly 
between the sham and SNT groups of either sex in the 
novel object recognition test (Fig. 5h, k).
Discussion
Our aim in this study was to assess whether the affec-
tive and cognitive deficits observed in patients with 
chronic pain are recapitulated in the SNT-induced 
mouse model of neuropathic pain, and, if so, whether 
Fig. 3 SNT induced depressive-like behavior in both male and female mice. a–d The forced swim (FST) and tail suspension tests (TST) were used 
to evaluate depressive-like behavior in male and female mice. The representative bar graph shows the immobility time in the FST and TST 8 weeks 
after SNT. Data are presented as the mean ± SEM, male: n = 9 for sham, n = 12 for SNT; female: n = 7 for sham, n = 8 for SNT. *P < 0.05, **P < 0.01, 
***P < 0.001 compared with the sham group
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sexual dimorphism exists in those chronic pain-associ-
ated affective and cognitive behaviors. Chronic neuro-
pathic pain caused by SNT does lead to depressive- and 
anxiety-like behavior in mice regardless of their sex, but 
it induces cognitive deficits only in male mice.
In humans, chronic neuropathic pain is often accom-
panied by affective disorders such as anxiety and 
depression that severely impair quality of life and com-
plicate therapeutic approaches. However, the comor-
bidity of affective disorders and chronic pain has 
been less pronounced in studies using animal models. 
Whereas depressive- and anxiety-like behaviors have 
been observed in some animal models of peripheral 
nerve injury, as evidenced by increased total immobil-
ity time in forced swim or tail suspension tests, other 
studies have reported no affective component in the 
dysfunctions caused by chronic pain [27–29]. We noted 
that those studies tested affective behavior at relatively 
early time points (within 2  weeks after pain induc-
tion), and we reasoned that neuropathic pain-related 
mood disorders might require a longer time to mani-
fest [30–33]. Therefore, we assessed chronic pain-asso-
ciated affective and cognitive behavioral abnormalities 
8 weeks post-injury and confirmed that depressive- and 
anxiety-like behaviors indeed develop at that delayed 
time point (8 weeks post-injury).
Fig. 4 SNT impaired spatial learning memory in male mice but not in female mice. SNT-injured male mice (a), but not female mice (b), required 
more time to escape onto the hidden platform compared with the sham group. Performances of sham and SNT-injured male (c–f) and female (g–j) 
mice in a Morris water maze probe trial. Time spent and swimming distance in the target quadrant were recorded. The total distance did not differ 
between the sham and SNT groups on the probe test. Data are presented as the mean ± SEM., male: n = 12 for sham, n = 12 for SNT; female: n = 12 
for sham, n = 12 for SNT. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the sham group
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The tail suspension and forced swim tests, behavioral 
assessments commonly used to measure depression in 
animals, were used to measure chronic pain-associated 
depression [34]. These tests have been used to evaluate 
the in  vivo efficacy of putative antidepressants for the 
treatment of pain-related depression [35–38]. In the pre-
sent study, we found depressive-like behavior in both 
male and female SNT-injured mice in the tail suspension 
Fig. 5 Cognitive deficits measured by the novel object location test were observed in male mice. Interaction time (s) spent exploring the 
object in the familiar location and the displaced object by male (a) and female (d) mice. b, e The discrimination index was defined as (displaced 
location − familiar location)/(displaced location + familiar location). c, f Total interaction time spent exploring an object in a familiar location 
and a displaced object. g, j Time spent exploring familiar and new objects in the test phase. h, k The discrimination index was defined as (new 
object − familiar object)/(new object + familiar object). i, l Total interaction time spent exploring the familiar object and new object (s). Data are 
presented as the mean ± SEM, male: n = 12 for sham, n = 12 for SNT; female: n = 12 for sham, n = 12 for SNT. *P < 0.05, **P < 0.01, ***P < 0.001 
compared with the sham group
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test (Fig.  3b, d), whereas depressive-like behavior was 
observed only in female mice in the forced swim test 
(Fig. 3c). So far, we do not have a clear explanation for the 
difference in sexual dimorphism of depressive behavior 
as measured by those two behavioral tests. Perhaps the 
tail suspension test is less stressful and has higher phar-
macologic sensitivity than the forced swim test [39]. The 
dopaminergic system is reportedly implicated in the per-
formance of mice in the forced swim test, whereas both 
the serotonergic and dopaminergic systems are involved 
in the tail suspension test [40]. However, other pharma-
cologic studies have suggested the involvement of both 
the serotonergic and noradrenergic systems in the forced 
swim test as well [41, 42]. It is conceivable that different 
neuropeptidergic systems are involved in the depressive-
like behavior observed in the forced swim and tail sus-
pension tests, and those differences might underlie the 
different outcomes we found.
Previous clinical studies have suggested that pain might 
be associated with cognitive impairment in humans and 
rodents [43]. The results from animal pain models have 
shown impaired learning and memory reflected through 
various tasks, such as the Morris water maze [44, 45], 
novel object recognition [46], and the Y-maze [47]. Con-
sistent with previous data, we observed significant defi-
cits in spatial memory acquisition and retention in the 
Morris water maze (Fig. 4a, c–f ) and in attention toward 
a novel location (Fig. 5a–c) in male mice after SNT. How-
ever, female mice with SNT did not show any changes in 
those tasks (Figs. 4b, g–j, 5d–f). Recently, sexual dimor-
phism in cognitive deficits after neuropathic pain was 
observed in a neuropathic pain mouse model [48]. In that 
study, male mice were more susceptible than female mice 
to pain-related cognitive deficits associated with mor-
phologic changes in the parvalbumin interneuron and 
pyramidal neuron in the infralimbic cortex in males. Sim-
ilarly, males were more prone to cognitive deficits caused 
by acute and chronic stress [49–51]. Male-specific altera-
tions in synapses and myelinated axons and decreased 
µ-opioid receptor signaling have been proposed as pos-
sible mechanisms of such sexual dimorphism [50, 52–
54]. However, no previous report has considered sexual 
dimorphism in the cognitive impairment of chronic pain 
patients, though a higher incidence of cognitive decline 
has been reported in male patients with Lewy body 
dementia, Parkinson disease dementia, and vascular 
dementia [55–58]. Several studies implicate sex hormone 
levels in cognitive impairment [59–61]. For instance, 
estrogen has been shown to enhance hippocampus-
dependent memory formation [62]. Estrogen replace-
ment therapy is widely used to reduce cognitive deficits 
in menopausal women [63]. Koyama et al. [64] showed a 
positive correlation between higher plasma estrogen and 
better cognitive performance. These results suggest that 
sex hormones might play a role in the sexual dimorphism 
of chronic pain-associated cognitive deficits observed in 
our study. Considering the prior studies, it will be worth-
while to test whether any of the mechanisms they discuss 
are involved in the sexual dimorphism observed in the 
Morris water maze and novel object location tests in our 
study.
Of interest, we found no significant difference between 
the sham and SNT groups in the novel object recogni-
tion test (Fig.  5g–l). The Morris water maze and novel 
object location tests assess hippocampal-dependent spa-
tial learning and memory [24, 65]. In contrast, the object 
recognition test relies on a variety of brain regions other 
than the hippocampus. Therefore, it is possible that 
chronic pain-induced cognitive deficits in males are asso-
ciated with a hippocampal abnormality. Indeed, putative 
functional disturbances in fronto-hippocampal connec-
tivity have been suggested as a relevant cause of pain-
involved working memory deficits in patients with pain. 
A smaller hippocampus was also observed in elderly 
patients with chronic pain. Hippocampal abnormalities 
associated with short-term memory deficits [66], rec-
ognition memory deficits [46], and deficits in long-term 
potentiation [67] have been reported in animal models of 
neuropathic pain. Considering the putative involvement 
of the hippocampus in chronic pain-associated cogni-
tive dysfunctions, it would be interesting to test whether 
hippocampal neurons are differentially affected by 
chronic pain depending on sex. That idea warrants future 
investigation.
Conclusion
Our study found that SNT-induced neuropathic pain 
led to depressive- and anxiety-like behavior and cogni-
tive deficits at a delayed time point in mice. Furthermore, 
we found sexual dimorphism in chronic pain-associated 
cognitive deficits. These results provide an animal model 
of sexually dimorphic cognitive deficits, and future stud-
ies could elucidate the pathogenic mechanisms of cogni-
tive deficits observed in neuropathic patients.
Abbreviation
SNT: L5 spinal nerve transection.
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